These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 12015035

  • 1. [Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer].
    Dong Q, Feng J, Huang J, Bao G, Sha H, Gu W.
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):142-6. PubMed ID: 12015035
    [Abstract] [Full Text] [Related]

  • 2. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
    Takigawa N, Segawa Y, Fujimoto N, Hotta K, Eguchi K.
    Anticancer Res; 1998 Mar; 18(2B):1251-4. PubMed ID: 9615796
    [Abstract] [Full Text] [Related]

  • 3. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 4. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Brodin O, Wagenius G.
    Anticancer Res; 1998 Sep 15; 18(2A):1123-7. PubMed ID: 9615776
    [Abstract] [Full Text] [Related]

  • 5. [Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer].
    Zhao J, Liu XY, Zhang QY, Jiang W.
    Zhonghua Zhong Liu Za Zhi; 2005 Nov 15; 27(11):676-9. PubMed ID: 16438890
    [Abstract] [Full Text] [Related]

  • 6. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
    Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, Watanabe G.
    Ann Surg Oncol; 2004 Oct 15; 11(10):928-33. PubMed ID: 15383417
    [Abstract] [Full Text] [Related]

  • 7. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E.
    Cancer Invest; 2006 Oct 15; 24(6):576-80. PubMed ID: 16982461
    [Abstract] [Full Text] [Related]

  • 8. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
    Fontanini G, Boldrini L, Chinè S, Pisaturo F, Basolo F, Calcinai A, Lucchi M, Mussi A, Angeletti CA, Bevilacqua G.
    Br J Cancer; 1999 Jan 15; 79(2):363-9. PubMed ID: 9888482
    [Abstract] [Full Text] [Related]

  • 9. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

  • 10. [The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer].
    Kopczyńska E, Dancewicz M, Kowalewski J, Kardymowicz H, Tyrakowski T.
    Pol Merkur Lekarski; 2007 Jun 03; 22(132):536-8. PubMed ID: 17874624
    [Abstract] [Full Text] [Related]

  • 11. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY, Liao ZS, Jiang SP, Zhang W, Li JG, Zheng DH.
    Ai Zheng; 2003 Jan 03; 22(1):86-90. PubMed ID: 12561444
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 13. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
    Ohta Y, Oda M, Wu J, Tsunezuka Y, Hiroshi M, Nonomura A, Watanabe G.
    J Thorac Cardiovasc Surg; 2001 Nov 15; 122(5):900-6. PubMed ID: 11689794
    [Abstract] [Full Text] [Related]

  • 14. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 15; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 15. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P, Orpana A, Joensuu H.
    Clin Cancer Res; 1999 Mar 15; 5(3):487-91. PubMed ID: 10100697
    [Abstract] [Full Text] [Related]

  • 16. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B.
    Clin Cancer Res; 2009 Mar 01; 15(5):1741-6. PubMed ID: 19240177
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T, Higashiyama M, Funai H, Imamura F, Uematsu K, Seki N, Eguchi K, Yamanaka T, Ichinose Y.
    Lung Cancer; 2006 Jul 01; 53(1):91-6. PubMed ID: 16697074
    [Abstract] [Full Text] [Related]

  • 18. [The clinical significance of vascular endothelial growth factor and intercellular adhesion molecule-1 expression in non-small cell lung cancer].
    Zhang HW, Zhang L, Chen JH, Du JJ.
    Zhonghua Wai Ke Za Zhi; 2005 Mar 15; 43(6):354-7. PubMed ID: 15854337
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E, Arias FC, Caso Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I, Moreno Balsalobre R, Sacristán López S, Gómez Pinillos A, del Val Toledo Lobo M.
    Cancer; 2009 Apr 15; 115(8):1701-12. PubMed ID: 19197998
    [Abstract] [Full Text] [Related]

  • 20. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P, Malugani F, Bonfanti A, Bucovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigoré L, Rovelli F, Mandalà M, Viviani S, Fumagalli L, Gardani GS.
    J Biol Regul Homeost Agents; 2001 Apr 15; 15(2):140-4. PubMed ID: 11501971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.